Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Symadex enters phase I in patients with advanced solid tumors

June 17, 2004

First patient enrolled in phase I/II study of TheraCIM hR3 for pediatric glioma

June 17, 2004

ZYC-101a shows 100% efficacy in patients with high-grade cervical dysplasia

June 17, 2004

Antitumor effects and safety of rhLF in advanced cancer patients

June 17, 2004

Novogen patent discloses isoflavonoid-based antiproliferative agents

June 16, 2004

New antitumor agents developed by Sanofi-Synthelabo scientists

June 16, 2004

Two series of mitotic kinesin KSP inhibitors claimed by Merck

June 16, 2004

Delayed tumor progression found with atrasentan in prostate cancer

June 16, 2004

ARRY-142886 enters phase I trial for advanced cancer

June 16, 2004

A6 enters phase II trial to prevent clinical relapse in ovarian cancer patients

June 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...